CBD retailers

CBD retailers will be getting people access to CBD at a lower cost. But the battle is about to hot up. Pharmaceutical companies are coming back at CBD retailers with pharmaceutical grade CBD products. GW Pharmaceuticals has launched the first FDA-approved CBD product, Epiliolex. It treats two rare forms of epilepsy in children with a price tag of $32,500 a year. According to the Arcview Market Research Editor in Chief, Tom Adams, said this was a drug people could access $32,500 a year. According Arcview Market Research Editor in Chief, Tom Adams, people could access CBD at a lower cost...